Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Thumbnail
Fulltext:
153431.pdf
Size:
119.3Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2015
Author(s)
Zwaginga, J.J.
Holt, B. van der
Boekhorst, P.A.W.
Biemond, B.J.
Levin, M.D.
Griend, R. van der
Brand, A.
Zweegman, S.
Pruijt, H.F.
Novotny, V.M.
Vreugdenhil, A.
Groot, M.R. de
Weerdt, O. de
Pampus, E.C.M. van
Maanen-Lamme, T.M. van
Wittebol, S.
Schipperus, M.R.
Silbermann, M.H.
Huijgens, P.C.
Luten, M.
Hollestein, R.
Brakenhoff, J.A.
Schrama, J.G.
Valster, F.A.
Velders, G.A.
Koene, H.R.
et al.
Source
Haematologica, 100, 3, (2015), pp. e90-2
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/153431   https://hdl.handle.net/2066/153431
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.